-
公开(公告)号:US20150114907A1
公开(公告)日:2015-04-30
申请号:US14522866
申请日:2014-10-24
申请人: Wisconsin Alumni Research Foundation , The United States of America as Represented by the Secretary of Agriculture, Washington, D.C.
发明人: Shaoqin GONG , Zhiyong Cai , Qifeng Zheng
CPC分类号: B01J20/3285 , B01J20/24 , B01J20/267 , B01J20/28007 , B01J20/28011 , B01J20/28023 , B01J20/28047 , B01J20/3078 , B01J20/3085 , C02F1/285 , C02F1/286 , C02F1/288 , C02F2101/20 , C02F2101/32 , C02F2305/08 , C08B15/02 , Y10T428/2982
摘要: Highly porous, lightweight, and sustainable organosilane-coated organic aerogels with ultra-low densities and excellent material properties and methods for preparing them are provided. The aerogels are modified to have a superhydrophobic and superoleophilic surface, thus leading to an extremely high affinity for oils and/or organic solvents.
摘要翻译: 提供了具有超低密度和优异的材料性质的高度多孔,轻质且可持续的有机硅烷涂覆的有机气凝胶,并且制备它们的方法。 气凝胶被改性为具有超疏水性和超亲油性表面,因此导致对油和/或有机溶剂的极高亲和力。
-
2.
公开(公告)号:US20140134415A1
公开(公告)日:2014-05-15
申请号:US14077103
申请日:2013-11-11
申请人: The United States of America as Represented by the Secretary of Agriculture , Wisconsin Alumni Research Foundation
发明人: Shaoqin GONG , Alireza JAVADI , Qifeng ZHENG , Zhiyong CAI , Ronald SABO
CPC分类号: C08J9/28 , C08J9/0076 , C08J2201/0484 , C08J2205/026 , C08J2300/14
摘要: Highly porous, lightweight, and sustainable hybrid organic aerogels with ultra-low densities and excellent material properties and methods for preparing them are provided, including, e.g., PVA/CNF/GONS, RF/CNF/GONS, and PVA/CNF/MWCNT. The aerogels are modified to have a super-hydrophobic surface, thus leading to an extremely low swelling ratio and rate of moisture absorption.
摘要翻译: 提供了具有超低密度和优异材料性质的高度多孔,轻质和可持续的混合有机气凝胶及其制备方法,包括例如PVA / CNF / GONS,RF / CNF / GONS和PVA / CNF / MWCNT。 气凝胶被改性为具有超疏水表面,因此导致非常低的溶胀比和吸湿率。
-
公开(公告)号:US20220105202A1
公开(公告)日:2022-04-07
申请号:US17501635
申请日:2021-10-14
发明人: Shaoqin GONG , Yuyuan Wang
摘要: The present technology provides a nanoparticle comprising: the polysiloxanes comprise silyloxy subunits having the structure (I) as shown herein, wherein Ra at each occurrence is independently selected from a bond to a Si of another polysiloxane chain or a C1-12 alkyl group; Ri at each occurrence is independently selected from the group consisting of C1-12 alkyl and C2-12 alkenyl groups, optionally substituted with a substituent selected from the group consisting of halogen and NR12, wherein each occurrence of R1 is independently selected from H or a C1-12 alkyl group, or two R1 groups, together with the N atom to which they are attached, form a pyrrolidine or piperidine ring; the crosslinks between polysiloxanes comprise disulfide linkages, the nanoparticle comprises an exterior surface comprising surface-modifying groups attached to and surrounding the silica network, wherein the surface-modifying groups comprise polyethylene glycol (PEG), polysarcosine, polyzwitterion, polycation, polyanion, or combinations of two or more thereof; and the nanoparticle has an average diameter of 15 nm to 200 nm. The nanoparticles herein may include biomolecules such as polynucleic acids, proteins, and complexes thereof, e.g., Cas9 RNP.
-
4.
公开(公告)号:US20190307888A1
公开(公告)日:2019-10-10
申请号:US16282174
申请日:2019-02-21
发明人: Shaoqin GONG , Yuyuan WANG , Krishanu SAHA , Amr Ashraf ABDEEN
摘要: Provided herein are nanoplexes comprising a payload selected from a protein and/or a polynucleic acid; and a plurality of copolymers comprising a first copolymer that is poly(N,N′-bis(acryloyl)cystamine-poly(aminoalkyl)) (PBAP), a second copolymer that is poly(C2-3 akylene glycol)-PBAP-poly(C2-3 akylene glycol), and a third copolymer that is TG-poly(C2-3 akylene glycol)-PBAP-poly(C2-3 akylene glycol)-TG wherein TG at each occurrence is independently a targeting ligand, a cell penetrating peptide, an imaging agent or a capping group, provided that a plurality of TG groups is a targeting ligand; wherein the payload is non-covalently complexed to one or more of the copolymers, one or more of the first, second, and/or third copolymers comprises an endosomal escape group having a pKa of about 4.5 to about 6.5, and optionally one or more of the first, second, and/or third copolymers comprises a host and a guest non-covalent crosslinker.
-
公开(公告)号:US20210346309A1
公开(公告)日:2021-11-11
申请号:US17331012
申请日:2021-05-26
发明人: Shaoqin GONG , Guojun CHEN
IPC分类号: A61K9/51 , A61K31/713 , A61P35/00
摘要: Provided are a unimolecular nanoparticle, a composition thereof, and methods of use thereof, and includes 1) a dendritic polymer having a molecular weight of about 500-120,000 Da and terminating in hydroxyl, amino or carboxylic acid groups; 2) cationic polymers attached to at least a majority of the terminating groups of the dendritic polymer via a pH-sensitive linker, wherein each cationic polymer comprises a polymeric backbone attached to cationic functional groups and to weakly basic groups by disulfide bonds, wherein the molar ratio of cationic functional groups to weakly basic groups ranges from 1:1-5:1, and has a molecular weight from about 1,000-5,000 Da; and 3) poly(ethylene glycol) attached to a plurality of cationic polymers and having a terminal group selected from a targeting ligand, OH, O-alkyl, NH2 , biotin, or a dye, wherein the terminal group of at least one poly(ethylene glycol) is having a molecular weight of about 1,000-15,000 Da.
-
公开(公告)号:US20210244752A1
公开(公告)日:2021-08-12
申请号:US17171463
申请日:2021-02-09
发明人: Shaoqin GONG , Mingzhou Ye
IPC分类号: A61K31/7048 , C08G69/10 , A61K47/59 , A61P31/04 , A61K31/7036 , A61K31/7056 , A61K31/496 , A61K38/14 , A61K31/426 , A61K31/4409
摘要: Provided herein are polymer-drug conjugates with enhanced antibacterial efficacy. These conjugates include a polymer comprising a plurality of masked cationic functional groups and an antibiotic drug linked to the cationic polymer by a pH-sensitive linker. The masked cationic functional groups may be converted in aqueous solution to free cationic functional groups faster at a pH below 7 than a pH above 7. The cationic functional groups may be masked as either an uncharged functional group or by an ion pair with a neighboring anionic functional group attached to the polymer. The pH-sensitive linker releases the drug faster in aqueous solution at or below a pre-determined pH value selected from a range of 4.5 to 7 than a pH value above 7.
-
公开(公告)号:US20180042844A1
公开(公告)日:2018-02-15
申请号:US15674293
申请日:2017-08-10
发明人: K. Craig KENT , Shaoqin GONG , Xudong SHI , Guojun CHEN , Lian-Wang GUO
IPC分类号: A61K9/107 , A61K31/436 , A61K47/34 , A61K9/06
CPC分类号: A61K9/1075 , A61K9/06 , A61K9/5146 , A61K9/5153 , A61K31/436 , A61K47/34
摘要: The present technology provide compositions that are drug delivery systems for the sustained release of anti-stenotic drugs for the treatment and prevention of occlusion of blood vessels, particularly after perivascular surgery. The compositions include a hydrogel, unimolecular micelles dispersed within the hydrogel, and an effective amount of anti-stenotic drug dispersed within the unimolecular micelle. The hydrogel may be a di-or tri-block copolymer comprising one block of poly(ethylene glycol) (PEG) and one or two blocks of poly(lactic-co-glycolic acid) (PLGA). The unimolecular micelle may include three domains: a dendritic polymer core, hydrophobic block polymers (e.g., PVL, PVCL, and/or PCL) attached to the core and PEG attached to the hydrophobic block polymers.
-
8.
公开(公告)号:US20200276130A1
公开(公告)日:2020-09-03
申请号:US16845938
申请日:2020-04-10
发明人: Shaoqin GONG , Wei XU , Yuyuan WANG , Fabao LIU
摘要: Provided herein are peptides comprising an amino acid sequence having at least about 85% sequence identity to RYRPRAPIIAVT (SEQ ID NO: 1). These cationic peptides inhibit PKM2 methylation and may be used in the treatment of breast cancer and other diseases or conditions in which PKM2 is overexpressed. Such PKM2 peptides may be delivered to cancer cells using pH sensitive unimolecular nanoparticles comprising anionic polymers.
-
公开(公告)号:US20180235897A1
公开(公告)日:2018-08-23
申请号:US15892140
申请日:2018-02-08
发明人: Shaoqin GONG , Wei XU , Yuyuan WANG , Fabao LIU
CPC分类号: A61K9/5146 , A61K9/513 , A61K38/005 , A61K38/10 , A61K47/595 , A61K47/60 , C07K7/08 , C07K17/06
摘要: Provided herein are peptides comprising an amino acid sequence having at least about 85% sequence identity to RYRPRAPIIAVT (SEQ ID NO: 1). These cationic peptides inhibit PKM2 methylation and may be used in the treatment of breast cancer and other diseases or conditions in which PKM2 is overexpressed. Such PKM2 peptides may be delivered to cancer cells using pH sensitive unimolecular nanoparticles comprising anionic polymers.
-
10.
公开(公告)号:US20220177494A1
公开(公告)日:2022-06-09
申请号:US17602239
申请日:2020-04-08
发明人: Shaoqin GONG , Yuyuan WANG
IPC分类号: C07F3/06 , A61K47/69 , A61K31/704 , A61K9/51 , A61K9/00
摘要: Provided herein are silica metal organic framework (SMOF) nanoparticles that are pH-responsive for delivery of bioactive molecules. The nanoparticles include a organosilica network comprising a plurality of imidazolyl and/or carboxyl groups; a metal organic framework component comprising a transition metal coordinated to a coordinating ligand, wherein the transition metal is selected from the group consisting of zinc, iron, zirconium, copper, and cobalt, and the coordinating ligand is selected from an imidazolate ligand or a carboxylate ligand; a bioactive payload selected from the group consisting of a hydrophilic drug, a polynucleic acid, a protein and a protein-polynucleic acid complex; and a surface-modifying polymer conjugated to the same or a different organosilica network and forming at least part of an exterior surface of the nanoparticle, wherein the surface-modifying polymer is selected from polyethylene glycol and/or a polyzwitterion; and wherein the zinc also coordinates the imidazolyl or carboxyl group of the organosilica network.
-
-
-
-
-
-
-
-
-